• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射频电流房室结导管消融术治疗药物难治性房性心律失常对心脏功能的影响

Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias.

作者信息

Twidale N, Sutton K, Bartlett L, Dooley A, Winstanley S, Heddle W, Hassam R, Koutsounis H

机构信息

Department of Medicine, Flinders Medical Centre, South Australia.

出版信息

Pacing Clin Electrophysiol. 1993 Jun;16(6):1275-84. doi: 10.1111/j.1540-8159.1993.tb01714.x.

DOI:10.1111/j.1540-8159.1993.tb01714.x
PMID:7686657
Abstract

Patients with atrial fibrillation or atrial flutter (AF) are candidates for radiofrequency (RF) catheter ablation of the atrioventricular (AV) node with the aim being to control heart rate. As patients with AF can have markedly impaired ventricular function, information concerning the hemodynamic effects of AV node ablation using RF current would be valuable. Fourteen consecutive patients (mean age 65 +/- 3 years) with drug-resistant AF underwent AV node catheter ablation with RF current and had permanent pacemaker implantation. The mean left ventricular ejection fraction (EF) by two-dimensional echocardiography immediately before ablation was 42 +/- 3% (range 14%-54%) and their mean exercise time was 4.4 +/- 0.4 minutes. Complete AV block was achieved in all 14 patients with 6 +/- 2 RF applications (range 1-18). There was no evidence of any acute cardiodepressant effect associated with delivery of RF current, and EF 3 days after ablation was 44 +/- 4%. By 6 weeks after ablation, the left ventricular EF was significantly improved compared to baseline (47 +/- 4% postablation vs 42 +/- 3% preablation; P < 0.05), and this modest increase in EF was accompanied by an improvement in exercise time (5.4 +/- 0.4 min). In conclusion, delivery of RF current for AV node catheter ablation in patients with AF and reduced ventricular function is not associated with any acute cardiodepressant effect. On the contrary, improved control of rapid heart rate following successful AV node ablation is associated with a modest and progressive improvement in cardiac performance.

摘要

心房颤动或心房扑动(AF)患者是房室(AV)结射频(RF)导管消融的候选对象,目的是控制心率。由于AF患者的心室功能可能明显受损,有关使用RF电流进行AV结消融的血流动力学效应的信息将很有价值。连续14例(平均年龄65±3岁)耐药性AF患者接受了RF电流下的AV结导管消融并植入了永久性起搏器。消融前通过二维超声心动图测得的平均左心室射血分数(EF)为42±3%(范围14%-54%),平均运动时间为4.4±0.4分钟。14例患者均通过6±2次RF应用(范围1-18次)实现了完全性房室传导阻滞。没有证据表明与RF电流传递相关的任何急性心脏抑制作用,消融后3天的EF为44±4%。到消融后6周时,左心室EF与基线相比有显著改善(消融后为47±4%,消融前为42±3%;P<0.05),EF的这种适度增加伴随着运动时间的改善(5.4±0.4分钟)。总之,对于AF和心室功能降低的患者,RF电流用于AV结导管消融与任何急性心脏抑制作用无关。相反,成功进行AV结消融后对快速心率的更好控制与心脏功能的适度且渐进性改善相关。

相似文献

1
Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias.射频电流房室结导管消融术治疗药物难治性房性心律失常对心脏功能的影响
Pacing Clin Electrophysiol. 1993 Jun;16(6):1275-84. doi: 10.1111/j.1540-8159.1993.tb01714.x.
2
Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias.因药物难治性房性快速性心律失常接受射频房室交界区消融和永久性起搏器植入术患者的心室功能及生活质量
J Interv Card Electrophysiol. 1998 Mar;2(1):71-6. doi: 10.1023/a:1009721008761.
3
The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.消融与起搏试验:一项关于房室传导系统导管消融及永久性起搏器植入治疗心房颤动的前瞻性研究。APT研究人员。
J Interv Card Electrophysiol. 1998 Jun;2(2):121-35. doi: 10.1023/a:1009795330454.
4
Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation.
Pacing Clin Electrophysiol. 1998 Apr;21(4 Pt 1):641-51. doi: 10.1111/j.1540-8159.1998.tb00119.x.
5
[Pharmacological versus invasive treatment in patients with atrial fibrillation].心房颤动患者的药物治疗与侵入性治疗对比
Pol Arch Med Wewn. 2004 Jun;111(6):703-7.
6
Modulation of atrioventricular conduction by ablation of the "slow" atrioventricular node pathway in patients with drug-refractory atrial fibrillation or flutter.药物难治性心房颤动或心房扑动患者中,通过消融“慢”房室结径路对房室传导进行调制。
J Am Coll Cardiol. 1995 Jan;25(1):39-46. doi: 10.1016/0735-1097(94)00315-h.
7
[Modulation of atrioventricular conduction in patients with atrial fibrillation or flutter. Immediate and long-term results].[心房颤动或心房扑动患者房室传导的调制。即时和长期结果]
Cardiologia. 1995 Dec;40(12):927-40.
8
Predictors of outcome after radiofrequency catheter ablation of the atrioventricular node for atrial fibrillation and congestive heart failure.
Am Heart J. 1998 Oct;136(4 Pt 1):647-57. doi: 10.1016/s0002-8703(98)70012-2.
9
Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation.通过射频导管改良房室结控制药物难治性心房颤动患者的快速心室率
Circulation. 1994 Nov;90(5):2299-307. doi: 10.1161/01.cir.90.5.2299.
10
Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation.心房颤动患者房室结射频改良后的长期随访
J Am Coll Cardiol. 1997 Jan;29(1):113-21. doi: 10.1016/s0735-1097(96)00445-7.

引用本文的文献

1
Safety of His-bundle ablation after pacemaker implantation in patients with persistent or permanent atrial fibrillation.起搏器植入术后持续性或永久性心房颤动患者希氏束消融的安全性
Herzschrittmacherther Elektrophysiol. 2025 Jun;36(2):132-137. doi: 10.1007/s00399-025-01082-w. Epub 2025 Jun 5.
2
Atrioventricular Nodal Catheter Ablation in Atrial Fibrillation Complicating Congestive Heart Failure.充血性心力衰竭合并心房颤动时的房室结导管消融术
J Atr Fibrillation. 2018 Jun 30;11(1):1813. doi: 10.4022/jafib.1813. eCollection 2018 Jun-Jul.
3
Pathophysiology, diagnosis and treatment of tachycardiomyopathy.
心动过速性心肌病的病理生理学、诊断与治疗
Heart. 2017 Oct;103(19):1543-1552. doi: 10.1136/heartjnl-2016-310391. Epub 2017 Aug 30.
4
Atrioventricular Junction Ablation In Atrial Fibrillation: Choosing The Right Patient And Pacing Device.心房颤动中的房室结消融:选择合适的患者和起搏装置。
J Atr Fibrillation. 2015 Aug 31;8(2):1253. doi: 10.4022/jafib.1253. eCollection 2015 Aug-Sep.
5
What About Tachycardia-induced Cardiomyopathy?心动过速性心肌病是怎么回事?
Arrhythm Electrophysiol Rev. 2013 Nov;2(2):82-90. doi: 10.15420/aer.2013.2.2.82.
6
Health-related quality of life relative to clinical outcomes in patients with atrial fibrillation treated with ventricular rate stabilisation pacing.心室率稳定起搏治疗心房颤动患者的健康相关生活质量与临床结局的关系
Neth Heart J. 2006 Mar;14(3):81-88.
7
Heart failure and tachycardia-induced cardiomyopathy.心力衰竭与心动过速性心肌病。
Curr Heart Fail Rep. 2013 Dec;10(4):296-306. doi: 10.1007/s11897-013-0150-z.
8
Temporal trends in permanent pacemaker implantation: a population-based study.永久性起搏器植入的时间趋势:一项基于人群的研究。
Am Heart J. 2008 May;155(5):896-903. doi: 10.1016/j.ahj.2007.12.022. Epub 2008 Feb 19.
9
Evolution of curative therapies for atrial fibrillation review.心房颤动治疗方法的演变综述。
Indian Pacing Electrophysiol J. 2004 Jan 1;4(1):10-25.
10
A perspective on rate control in the treatment of atrial fibrillation.心房颤动治疗中率控制的观点。
Clin Cardiol. 2004 Mar;27(3):121-4. doi: 10.1002/clc.4960270304.